These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease. Werner FM; Covenas R Curr Pharm Des; 2016; 22(14):2064-71. PubMed ID: 26818863 [TBL] [Abstract][Full Text] [Related]
7. Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease. Wicke K; Haupt A; Bespalov A Expert Opin Investig Drugs; 2015; 24(12):1515-28. PubMed ID: 26548316 [TBL] [Abstract][Full Text] [Related]
11. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders. Nirogi R; Jayarajan P; Shinde A; Mohammed AR; Grandhi VR; Benade V; Goyal VK; Abraham R; Jasti V; Cummings J Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830678 [TBL] [Abstract][Full Text] [Related]
12. Idalopirdine as a treatment for Alzheimer's disease. Galimberti D; Scarpini E Expert Opin Investig Drugs; 2015; 24(7):981-7. PubMed ID: 26022777 [TBL] [Abstract][Full Text] [Related]
13. The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders. Millan MJ; Rivet JM; Gobert A J Psychopharmacol; 2016 Nov; 30(11):1099-1128. PubMed ID: 27756833 [TBL] [Abstract][Full Text] [Related]
14. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589 [TBL] [Abstract][Full Text] [Related]
15. The potential role of dopamine D₃ receptor neurotransmission in cognition. Nakajima S; Gerretsen P; Takeuchi H; Caravaggio F; Chow T; Le Foll B; Mulsant B; Pollock B; Graff-Guerrero A Eur Neuropsychopharmacol; 2013 Aug; 23(8):799-813. PubMed ID: 23791072 [TBL] [Abstract][Full Text] [Related]
17. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Li Z; Huang M; Prus AJ; Dai J; Meltzer HY Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474 [TBL] [Abstract][Full Text] [Related]